Pfizer announced detailed progression-free and overall survival results from Cohort 3, a randomized cohort of the Phase...
survival
UCB (Euronext Brussels: UCB), a global biopharmaceutical company, today announced that the European Commission (EC) has granted...
The bacteria Acinetobacter baumannii (A. baumannii) is a haunting presence in many hospitals in the United States, where more than...
Eyes may be the window to the soul, but a person’s biological age could be reflected in...
Studies reported at ESMO 2024 reveal new groups of women with early-stage endometrial (1) and cervical cancers...
A new study shows that by combining different chemotherapy drugs, testicular cancer remains highly treatable and often...
Roche ha annunciato risultati statisticamente e clinicamente significativi dello studio di Fase III STARGLO relativi alla combinazione...
Grant of up to $11 million will fund a clinical trial at UCSF that uses a smarter...
The Swiss Group for Clinical Cancer Research (SAKK) has announced that the patient recruitment of the phase...
Daiichi Sankyo Company, Limited announced that positive results from the pivotal QuANTUM-R phase 3 study of single...